Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 104.44M P/E - EPS this Y -130.90% Ern Qtrly Grth -
Income -35.39M Forward P/E 2.25 EPS next Y 132.60% 50D Avg Chg 3.00%
Sales 9.67M PEG - EPS past 5Y - 200D Avg Chg 24.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -25.00%
Recommedations 1.60 Quick Ratio 3.68 Shares Outstanding 37.86M 52W Low Chg 149.00%
Insider Own 1.17% ROA -24.70% Shares Float 37.47M Beta 1.50
Inst Own 36.96% ROE -46.12% Shares Shorted/Prior 0.99M/1.08M Price 2.86
Gross Margin -55.83% Profit Margin - Avg. Volume 326,843 Target Price 6.50
Oper. Margin -1,255.03% Earnings Date Nov 11 Volume 77,925 Change -2.05%
About SCYNEXIS, Inc.

SCYNEXIS, Inc., a biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States. It offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, an intravenous drug for the treatment of invasive candidiasis and/or candidemia, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It also develops SCY-247 to treat systemic fungal diseases. The company has licensing and collaboration agreements with GlaxoSmithKline Intellectual Property (No. 3) Limited, Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC for the development, manufacture, and commercialization of ibrexafungerp. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

SCYNEXIS, Inc. News
11/08/24 SCYNEXIS Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
11/06/24 Scynexis: Q3 Earnings Snapshot
11/06/24 SCYNEXIS Reports Third Quarter 2024 Financial Results and Provides Corporate Update
10/30/24 Investors in SCYNEXIS (NASDAQ:SCYX) have unfortunately lost 89% over the last five years
10/10/24 SCYNEXIS to Participate in the 2024 Maxim Healthcare Virtual Summit
10/03/24 SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at IDWeek 2024
08/27/24 SCYNEXIS to Participate in H. C. Wainwright 26th Annual Global Investment Conference
08/10/24 SCYNEXIS Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
08/08/24 Scynexis: Q2 Earnings Snapshot
08/08/24 SCYNEXIS Reports Second Quarter 2024 Financial Results and Provides Corporate Update
07/23/24 SCYNEXIS to Receive $10 Million Milestone Payment from GSK Triggered by Delivery of Completed FURI, CARES and NATURE Clinical Study Reports
07/22/24 3 Stocks Under $10 With the Potential for Massive Gains
05/31/24 Hidden Gems: 3 Under-$10 Stocks Poised for 500% Growth by 2025
05/23/24 3 Stocks Under $10 With Mammoth Growth Prospects
05/08/24 SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update
05/08/24 Investors in SCYNEXIS (NASDAQ:SCYX) have unfortunately lost 87% over the last five years
04/30/24 SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID)
04/09/24 SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
03/28/24 SCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate Update
01/30/24 SCYNEXIS to Participate in Guggenheim’s 6th Annual Biotechnology Conference
SCYX Chatroom

User Image pantarei Posted - 5 hours ago

$SCYX the null company. Does it really still exsist?

User Image pjinvestmentco Posted - 13 hours ago

$SCYX Under $1 coming soon unless they sell to GSK

User Image SeekingapeacefulpathMill Posted - 13 hours ago

$SCYX These studies such as Mario are important. How can you justify doing a voluntary recall ( basically ) then going into the 15 th month. That is unacceptable and shelf life tests don't take this long . 🤔☘️💵

User Image Pommy1 Posted - 1 day ago

$SCYX lets go up up up up n up

User Image Pommy1 Posted - 2 days ago

$SCYX lets go i m so excited about the news

User Image Pommy1 Posted - 2 days ago

$SCYX wt co is saying about this disaster

User Image pjinvestmentco Posted - 2 days ago

$SCYX Once this goes under $1 it will be in control by the pump and dump traders and naked shorts. This could be under $1 this week

User Image pantarei Posted - 3 days ago

$SCYX are we near to the end? Brexafemme totally disappeared fron radar

User Image SnapCrackleStop Posted - 3 days ago

$SCYX This is all and of year BS tax selling. If you know what $SCYX has and the company is fully funded for 2 years you know this valuation is crazy. Everyone on the Board and C-Suite knows what they have. They are shareholders too. GSK knows also. They ponied up over $100 mm Adding here. Wait for 2025. $$$

User Image pantarei Posted - 3 days ago

$SCYX POS!!!!

User Image Pommy1 Posted - 3 days ago

$SCYX gsk got terms to buy.all clowns need to resign first lol

User Image pjinvestmentco Posted - 3 days ago

$SCYX Sell to GSK or risk of going under $1

User Image pantarei Posted - 5 days ago

$SCYX Clowns 🤡

User Image PenkeTrading Posted - 5 days ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Scynexis Inc. Is that bullish or bearish? $SCYX #Scynexis #RsiOversold #NASDAQ

User Image Pommy1 Posted - 6 days ago

$SCYX wt 1.15 or 1.10 on monday

User Image LemuelPitkin Posted - 6 days ago

$SCYX Know what you own: NoSCYX has never produced a murder-product. SCYX has not pressured Government to mandate the murder of pregnant women and kids by mandating the mRNA clot-shots. People were never fired for refusing to take a product produced by SCYX. What SCYX has produced is a first-in-3-decades new antifungal drug capable of treating a wide range of drug resistant fungal infections that likely is safe in pregnancy (we still are collecting the proof of that).

User Image SnapCrackleStop Posted - 6 days ago

$SCYX Now why would Avidity Partners take a 10% stake in Scynexis??? FROM 13G Avidity now owns 9.8% of SCYX. Established in April 2019, Avidity Partners Management is a healthcare-focused hedge fund manager managed by Michael Gregory, former Highland Capital executive and David Witzke, former Citadel portfolio manager. The firm seeks to generate high positive returns across all market and economic cycles through investments primarily in equity securities of U.S. publicly-traded companies within the healthcare sector. $$$$

User Image LemuelPitkin Posted - 6 days ago

$SCYX Now is the time to separate the wheat from the chaff. Do you know SCYX? Do you know what we own? "Pharma stocks down!" Are you the "casual investor" sporting a tiny bird-brain who flits away afraid of a gust of wind? Are you a dangerously arrogant, dimwitted Wall Street "hotshot" whose algos do the trading without regard for what is actually traded/the nature of the company and IP? The algo says sell! So these paper handed bitchz are selling. Bye bye to them. There is no "pharma sector". There are individual companies. Know what you own: SCYX has never produced a murder-product. SCYX has not pressured Government to mandate the murder of pregnant women and kids by mandating the mRNA clot-shots. People were never fired for refusing to take a product produced by SCYX. What SCYX has produced is a first-in-3-decades new antifungal drug capable of treating a wide range of drug resistant fungal infections that likely is safe in pregnancy (we still are collecting the proof of that).

User Image btm811 Posted - 6 days ago

$SCYX this has always gradually going downhill regardless, but that idiot RFK Jr being appointed and being the collective nail in the coffin here is extra brutal

User Image pjinvestmentco Posted - 6 days ago

$SCYX tick tock to under $1

User Image Pommy1 Posted - 6 days ago

$SCYX is this good news or bad 7:23 < Back News Form SC 13G A SCYNEXIS INC Filed by: Avidity Partners Management LP US Securities and Exchange Commission 07:08PM ET, 11/14/2024 5G: 70 http://archive.fast- edgar.com/20241114/AWZ29622H222TZZZ25272ZZIU3AA! Filed on: November 14, R024 Companies Mentioned in this story SCYNEXIS Inc SCYX: NASDAQ Last Price 1.26 Today's Change • (0.00%) Mon t Thu Delayed quotes, as of 4:00:00 pm ET, 11/14/2024 Ill Accounts 名 Watchlist Trade Markets More

User Image pantarei Posted - 6 days ago

$SCYX a huge fail. Probably worst managed company ever. A shame for management

User Image pjinvestmentco Posted - 1 week ago

$SCYX $1.23 a slow ride down to under $1 where the pump and dump traders will takeover the company

User Image Pommy1 Posted - 1 week ago

$SCYX question to management are u guys even doing anything to fix ur mess

User Image pjinvestmentco Posted - 1 week ago

$SCYX tick tock to 90 cents

User Image btm811 Posted - 1 week ago

$SCYX If only a large publication would devote a story to the worst managed company in America, its actually quite astounding how inept it is from top to bottom

User Image Pommy1 Posted - 1 week ago

$SCYX viktor they are hard headed people .dont get ur ideas

User Image ViktorSinclair Posted - 1 week ago

$SCYX Unfortunately scyx management never understood to “over deliver” and do it on time. You can’t say in Q4 this will happen then in Q4 you say perhaps in Q1. If you say Q4 you over deliver in Q3 and no later that early Q4. they are just not savy ws guys, i wish the science guys would just stick to science and leave the business calls to savy experienced biotech ceos with business backgrounds. they just keep stepping on their own crank time and time again. let me give you some food for thought… Take the 10 mil and do a stock buy back. this will jump start the stock and encourage investment. follow that move with some positive technical news with pr’s that focus on the potential impact on the company from a business perspective not just science.

User Image pjinvestmentco Posted - 1 week ago

$SCYX There is only 2 announcements coming for the next 6 to 9 months from Scynexis 1. Start Phase 1 SCY-247 2. Start Phase 3 Mario trial possible 3rd would be Hansoh approval in China. The bottom line there isn't any big market moving news this could languish under $2 for 2025

User Image Pommy1 Posted - 1 week ago

$SCYX why david not buying the stock anymore

Analyst Ratings
Cantor Fitzgerald Overweight Apr 1, 24
Cantor Fitzgerald Overweight Aug 15, 23
Guggenheim Buy Apr 3, 23
Ladenburg Thalmann Buy Apr 3, 23
Guggenheim Buy Mar 1, 23
HC Wainwright & Co. Buy May 13, 22
HC Wainwright & Co. Buy Mar 31, 22
Aegis Capital Buy Jun 7, 21
Aegis Capital Buy Apr 12, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Taglietti Marco Chief Executive Offi.. Chief Executive Officer Apr 26 Buy 3.00 75,000 225,000 272,068 04/28/22
Sukenick Scott General Counsel General Counsel Apr 26 Buy 3.00 3,500 10,500 53,499 04/28/22
- - - Jan 26 Sell 7.98 599,000 4,780,020 1,800,000 01/26/21